Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Aug;46(2):300–303. doi: 10.1038/bjc.1982.198

Further studies on the protection by an F1 tumour against GvHR induced in F1 mice by injection of parental spleen cells.

D B Palmer, T Whitmarsh-Everiss, M O Symes
PMCID: PMC2011077  PMID: 7150479

Full text

PDF
300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradfield J. W., Whitmarsh-Everiss T., Palmer D. B., Payne R., Symes M. O. Hyperphagocytosis and the effect of lipopolysaccharide injection in tumour-bearing mice. Br J Cancer. 1980 Dec;42(6):900–907. doi: 10.1038/bjc.1980.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cantarow W. D., Cheung H. T., Sundharadas G. Modulation of spreading, adhesion and migration of peritoneal macrophages by a low molecular weight factor extracted from mouse tumors. J Reticuloendothel Soc. 1978 Dec;24(6):657–666. [PubMed] [Google Scholar]
  3. Cheung H. T., Cantarow W. D., Sundharadas G. Tumoricidal activity of macrophages induced by lipopolysaccharide and its inhibition by a low molecular weight factor extracted from tumors. J Reticuloendothel Soc. 1979 Jul;26(1):21–30. [PubMed] [Google Scholar]
  4. Ferluga J., Allison A. C. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet. 1978 Sep 16;2(8090):610–611. doi: 10.1016/s0140-6736(78)92828-3. [DOI] [PubMed] [Google Scholar]
  5. HOWARD J. Changes in the activity of the reticulo-endothelial system (RES) following the injection of parental spleen cells into F1 hybrid mice. Br J Exp Pathol. 1961 Feb;42:72–82. [PMC free article] [PubMed] [Google Scholar]
  6. Milas L., Hunter N., Mason K., Withers H. R. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 1974 Jan;34(1):61–71. [PubMed] [Google Scholar]
  7. Nelson M., Nelson D. S. Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages. Immunology. 1978 Feb;34(2):277–290. [PMC free article] [PubMed] [Google Scholar]
  8. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Shands J. W., Jr, Senterfitt V. C. Endotoxin-induced hepatic damage in BCG-infected mice. Am J Pathol. 1972 Apr;67(1):23–40. [PMC free article] [PubMed] [Google Scholar]
  10. Snyderman R., Pike M. C. An inhibitor of macrophage chemotaxis produced by neoplasms. Science. 1976 Apr 23;192(4237):370–372. doi: 10.1126/science.946556. [DOI] [PubMed] [Google Scholar]
  11. Vassef A. A. Direct micromethod for colorimetry of serum ornithine carbamoyltransferase activity, with use of a linear standard curve. Clin Chem. 1978 Jan;24(1):101–107. [PubMed] [Google Scholar]
  12. Whitmarsh-Everiss T., Symes M. O. The presence of a tumour in F1 mice partially inhibits the GvH reaction following injection of parental spleen cells. Br J Cancer. 1981 Mar;43(3):305–311. doi: 10.1038/bjc.1981.48. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES